Objective: To determine whether the reported drug-drug interaction between the flea medication spinosad and ivermectin is attributable to inhibition of P-glycoprotein by spinosad.
Animals: 6 healthy adult dogs with the ABCB1 wildtype genotype.
Procedures: The study was conducted as a prospective, masked, randomized crossover design.